LIVIVO - Search results -

Search results

Result 1 - 10 of total 23

Article ; Online: Two

Bouzidi, Sarah / Puech, Julien / Fulla, Marta / González-Compta, Xavier / Pere, Hélène / Alemany, Laia / Veyer, David / Bravo, Ignacio G

Microbiology resource announcements

2024 Volume 13, Issue 4, Page(s) e0118423

Abstract: We communicate here two ... ...

Abstract	We communicate here two complete
Language	English
Publishing date	2024-03-05
Publishing country	United States
Document type	Journal Article
ISSN	2576-098X
ISSN (online)	2576-098X
DOI	10.1128/mra.01184-23
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Nirmatrelvir and Ritonavir combination in COVID-19 patients with advanced chronic kidney disease.

Lafont, Emmanuel / Blez, Damien / Bildan, Marc-Antoine / Veyer, David / Péré, Hélène / Puech, Julien / Kably, Benjamin / Cheminet, Geoffrey / Pouchot, Jacques / Thervet, Eric / Peytavin, Gilles / Lazareth, Helene

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

2023

Language	English
Publishing date	2023-12-30
Publishing country	United States
Document type	Journal Article
ZDB-ID	1099781-7
ISSN	1537-6591 ; 1058-4838
ISSN (online)	1537-6591
ISSN	1058-4838
DOI	10.1093/cid/ciad785
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1505: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 480: Show issues

Order via subito

Details ▾

Article ; Online: Human papillomavirus genotype distribution by cytological status and associated risk factors in the general population of Congolese women living in urban and rural areas: Implications for cervical cancer prevention.

Tsimba Lemba, Paola Candyse / Boumba, Luc Magloire Anicet / Péré, Hélène / Nganga, Parfait Christy / Veyer, David / Puech, Julien / Mboumba Bouassa, Ralph-Sydney / Malanda-Kiminou, Privat / Moukassa, Donatien / Bélec, Laurent

Infectious diseases now

2023 Volume 53, Issue 8, Page(s) 104762

Abstract: Introduction: Cervical cancer related to high risk-human papillomavirus (HR-HPV) is the second female cancer in the Republic of Congo (Congo). We herein evaluated the molecular epidemiology of cervical HPV infection and associated risk factors in ... ...

Abstract	Introduction: Cervical cancer related to high risk-human papillomavirus (HR-HPV) is the second female cancer in the Republic of Congo (Congo). We herein evaluated the molecular epidemiology of cervical HPV infection and associated risk factors in Congolese women living in urban (Brazzaville) and rural (Plateaux department) settings. Patients and methods: A population-based, cross-sectional survey was conducted to collect demographic and behavioral data among Congolese women, and to obtain endocervical swab samples for HPV DNA molecular detection (Anyplex II HPV28, Seegene, Seoul, South Korea). Results: A total of 284 women (mean age: 37.8 years; HIV-1-positivity: 18.6%) were included. The prevalence of HPV DNA cervical shedding was 64.4% [HR-HPV: 80.9%, mainly HPV-16 (15.8%), and HPV-35 and HPV-52 (15.3%); multiple HPV infections: 60.6%; 9-valent HPV Gardasil-9® vaccine genotypes: 42.6%]. 91.6% and 100% of low-grade squamous intraepithelial neoplasia (LSIL) and cervical cancer, respectively, showed HR-HPV. HR-HPV prevalence was higher among students (aOR: 7.9) and HIV-infected women (aOR: 3.1) in Brazzaville, and among women aged between 21-30 years (aOR: 7.2) and HIV-infected women (aOR: 5.1) in the Plateaux department. Conclusion: Cervical HR-HPV infection is particularly frequent in young or HIV-infected Congolese women. Prophylactic HPV vaccination combined with primary molecular screening of HR-HPV infection in this country should be extended.
MeSH term(s)	Humans ; Female ; Young Adult ; Adult ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/prevention & control ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/prevention & control ; Human Papillomavirus Viruses ; Cross-Sectional Studies ; Risk Factors ; HIV Infections/epidemiology ; DNA ; Genotype
Chemical Substances	DNA (9007-49-2)
Language	English
Publishing date	2023-07-14
Publishing country	France
Document type	Journal Article
ISSN	2666-9919
ISSN (online)	2666-9919
DOI	10.1016/j.idnow.2023.104762
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- Full text online
- Order with fees

Article ; Online: Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.

Kervarrec, Thibault / Imbeaud, Sandrine / Veyer, David / Pere, Helene / Puech, Julien / Pekár-Lukacs, Agnes / Markiewicz, Dorota / Coutts, Michael / Tallet, Anne / Collin, Christine / Berthon, Patricia / Bravo, Ignacio G / Seris, Alice / Jouary, Thomas / Macagno, Nicolas / Touzé, Antoine / Cribier, Bernard / Battistella, Maxime / Calonje, Eduardo

The American journal of surgical pathology

2023 Volume 47, Issue 10, Page(s) 1077–1084

Abstract: Digital papillary adenocarcinoma (DPA) is a rare sweat gland neoplasm that has exceptionally been reported outside acral locations. Recently, human papillomavirus 42 was identified as the main oncogenic driver of DPA. Herein, we report 5 tumors arising ... ...

Abstract	Digital papillary adenocarcinoma (DPA) is a rare sweat gland neoplasm that has exceptionally been reported outside acral locations. Recently, human papillomavirus 42 was identified as the main oncogenic driver of DPA. Herein, we report 5 tumors arising in extra-acral locations predominantly in the female anogenital skin. Four patients were female and 1 patient was male. The mean age at the diagnosis time was 65 years (range: 55 to 82 y). Tumors were located on the vulva (n=3), perianal area (n=1), and forearm (n=1). Histologically, all tumors were lobular and mainly solid and composed of sheets of cells with rare focal papillae and frequent glandular structures in a "back-to-back" pattern and lined by atypical basophilic cells. Immunohistochemistry showed diffuse positivity for SOX10. Epithelial membrane antigen and carcinoembryonic antigen highlighted the luminal cells and staining for p63 and p40 revealed a consistent and continuous myoepithelial component around glandular structures. Follow-up was available in 3 cases (mean duration: 12 mo [range: 8 to 16 mo]). One patient developed local recurrence and 1 experienced regional lymph node metastases. HPV Capture Next-generation sequencing revealed the presence of the HPV42 genome in all samples. Viral reads distributions were compatible in the 5 cases with an episomal nature of the viral genome, with a recurrent deletion in the E1 and/or E2 open reading frames. In conclusion, this study demonstrates that digital DPA may rarely present in nonacral locations mainly in the female anogenital area, usually with a more solid pattern as compared with those cases presenting on the digits and it is also associated with HPV42.
MeSH term(s)	Humans ; Male ; Female ; Middle Aged ; Aged ; Aged, 80 and over ; Sweat Gland Neoplasms/chemistry ; Bone Neoplasms ; Breast Neoplasms ; Neoplasms, Connective Tissue ; Biomarkers, Tumor/genetics ; Adenocarcinoma, Papillary/pathology
Chemical Substances	Biomarkers, Tumor
Language	English
Publishing date	2023-07-31
Publishing country	United States
Document type	Journal Article
ZDB-ID	752964-8
ISSN	1532-0979 ; 0147-5185
ISSN (online)	1532-0979
ISSN	0147-5185
DOI	10.1097/PAS.0000000000002096
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1356: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients.

Bruel, Timothée / Vrignaud, Lou-Léna / Porrot, Françoise / Staropoli, Isabelle / Planas, Delphine / Guivel-Benhassine, Florence / Puech, Julien / Prot, Matthieu / Munier, Sandie / Henry-Bolland, William / Soulié, Cathia / Zafilaza, Karen / Lusivika-Nzinga, Clovis / Meledge, Marie-Laure / Dorival, Céline / Molino, Diana / Péré, Hélène / Yordanov, Youri / Simon-Lorière, Etienne /

Veyer, David / Carrat, Fabrice / Schwartz, Olivier / Marcelin, Anne-Geneviève / Martin-Blondel, Guillaume

medRxiv : the preprint server for health sciences

2023

Abstract: Background: Monoclonal antibodies (mAbs) targeting the spike of SARS-CoV-2 prevent severe COVID-19. Omicron subvariants BQ.1.1 and XBB.1.5 evade neutralization of therapeutic mAbs, leading to recommendations against their use. Yet, the antiviral ... ...

Abstract	Background: Monoclonal antibodies (mAbs) targeting the spike of SARS-CoV-2 prevent severe COVID-19. Omicron subvariants BQ.1.1 and XBB.1.5 evade neutralization of therapeutic mAbs, leading to recommendations against their use. Yet, the antiviral activities of mAbs in treated patients remain ill-defined. Methods: We investigated neutralization and antibody-dependent cellular cytotoxicity (ADCC) of D614G, BQ.1.1 and XBB.1.5 in 320 sera from 80 immunocompromised patients with mild-to-moderate COVID-19 prospectively treated with mAbs (sotrovimab, n=29; imdevimab/casirivimab, n=34; cilgavimab/tixagevimab, n=4) or anti-protease (nirmatrelvir/ritonavir, n=13). We measured live-virus neutralization titers and quantified ADCC with a reporter assay. Findings: Only Sotrovimab elicits serum neutralization and ADCC against BQ.1.1 and XBB.1.5. As compared to D614G, sotrovimab neutralization titers of BQ.1.1 and XBB.1.5 are reduced (71- and 58-fold, respectively), but ADCC levels are only slightly decreased (1.4- and 1-fold, for BQ.1.1 and XBB.1.5, respectively). Interpretation: Our results show that sotrovimab is active against BQ.1.1 and XBB.1.5 in treated individuals, suggesting that it may be a valuable therapeutic option.
Language	English
Publishing date	2023-05-30
Publishing country	United States
Document type	Preprint
DOI	10.1101/2023.05.25.23290512
Database	MEDical Literature Analysis and Retrieval System OnLINE

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.

Planas, Delphine / Bruel, Timothée / Staropoli, Isabelle / Guivel-Benhassine, Florence / Porrot, Françoise / Maes, Piet / Grzelak, Ludivine / Prot, Matthieu / Mougari, Said / Planchais, Cyril / Puech, Julien / Saliba, Madelina / Sahraoui, Riwan / Fémy, Florent / Morel, Nathalie / Dufloo, Jérémy / Sanjuán, Rafael / Mouquet, Hugo / André, Emmanuel /

Hocqueloux, Laurent / Simon-Loriere, Etienne / Veyer, David / Prazuck, Thierry / Péré, Hélène / Schwartz, Olivier

Nature communications

2023 Volume 14, Issue 1, Page(s) 824

Abstract: Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The subvariant BQ.1.1 became predominant in many countries in December 2022. The ... ...

Abstract	Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The subvariant BQ.1.1 became predominant in many countries in December 2022. The subvariants carry an additional and often redundant set of mutations in the spike, likely responsible for increased transmissibility and immune evasion. Here, we established a viral amplification procedure to easily isolate Omicron strains. We examined their sensitivity to 6 therapeutic monoclonal antibodies (mAbs) and to 72 sera from Pfizer BNT162b2-vaccinated individuals, with or without BA.1/BA.2 or BA.5 breakthrough infection. Ronapreve (Casirivimab and Imdevimab) and Evusheld (Cilgavimab and Tixagevimab) lose antiviral efficacy against BA.2.75.2 and BQ.1.1, whereas Xevudy (Sotrovimab) remaine weakly active. BQ.1.1 is also resistant to Bebtelovimab. Neutralizing titers in triply vaccinated individuals are low to undetectable against BQ.1.1 and BA.2.75.2, 4 months after boosting. A BA.1/BA.2 breakthrough infection increases these titers, which remains about 18-fold lower against BA.2.75.2 and BQ.1.1, than against BA.1. Reciprocally, a BA.5 breakthrough infection increases more efficiently neutralization against BA.5 and BQ.1.1 than against BA.2.75.2. Thus, the evolution trajectory of novel Omicron subvariants facilitates their spread in immunized populations and raises concerns about the efficacy of most available mAbs.
MeSH term(s)	Humans ; Antibodies, Neutralizing ; Antibodies, Viral ; Antiviral Agents ; BNT162 Vaccine ; Breakthrough Infections ; COVID-19/immunology ; COVID-19/prevention & control ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus/genetics
Chemical Substances	Antibodies, Neutralizing ; Antibodies, Viral ; Antiviral Agents ; BNT162 Vaccine ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
Language	English
Publishing date	2023-02-14
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
ZDB-ID	2553671-0
ISSN	2041-1723 ; 2041-1723
ISSN (online)	2041-1723
ISSN	2041-1723
DOI	10.1038/s41467-023-36561-6
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.

Bruel, Timothée / Vrignaud, Lou-Léna / Porrot, Françoise / Staropoli, Isabelle / Planas, Delphine / Guivel-Benhassine, Florence / Puech, Julien / Prot, Matthieu / Munier, Sandie / Bolland, William Henry / Soulié, Cathia / Zafilaza, Karen / Lusivika-Nzinga, Clovis / Meledge, Marie-Laure / Dorival, Céline / Molino, Diana / Péré, Hélène / Yordanov, Youri / Simon-Lorière, Etienne /

Veyer, David / Carrat, Fabrice / Schwartz, Olivier / Marcelin, Anne-Geneviève / Martin-Blondel, Guillaume

Med (New York, N.Y.)

2023 Volume 4, Issue 10, Page(s) 664–667

Abstract: Antibodies effective against the recent Omicron sublineages are missing. By taking advantage of a multi-centric prospective cohort of immunocompromised individuals treated for mild-to-moderate COVID-19, Bruel et al. show that administration of 500 mg of ... ...

Abstract	Antibodies effective against the recent Omicron sublineages are missing. By taking advantage of a multi-centric prospective cohort of immunocompromised individuals treated for mild-to-moderate COVID-19, Bruel et al. show that administration of 500 mg of sotrovimab induces serum neutralization and antibody-dependent cellular cytotoxicity of BQ.1.1 and XBB.1.5. Therefore, sotrovimab may remain a therapeutic option against these variants.
MeSH term(s)	Humans ; Prospective Studies ; Antibodies, Monoclonal, Humanized/therapeutic use ; Immunocompromised Host ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use
Chemical Substances	sotrovimab (1MTK0BPN8V) ; Antibodies, Monoclonal, Humanized ; Antiviral Agents
Language	English
Publishing date	2023-10-16
Publishing country	United States
Document type	Letter ; Research Support, Non-U.S. Gov't
ISSN	2666-6340
ISSN (online)	2666-6340
DOI	10.1016/j.medj.2023.07.007
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- Full text online
- Order with fees

Article: Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual.

Kernéis, Solen / Planas, Delphine / Imbeaud, Sandrine / Staropoli, Isabelle / Puech, Julien / Robillard, Nicolas / Rodary, Julien / Bruel, Timothée / Vieillard, Thomas / Schwartz, Olivier / Belec, Laurent / Péré, Hélène / Veyer, David

Open forum infectious diseases

2021 Volume 8, Issue 8, Page(s) ofab369

Abstract: Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a ... ...

Abstract	Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.
Language	English
Publishing date	2021-07-20
Publishing country	United States
Document type	Journal Article
ZDB-ID	2757767-3
ISSN	2328-8957
ISSN	2328-8957
DOI	10.1093/ofid/ofab369
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood.

Péré, Hélène / Vernet, Raphael / Pernot, Simon / Pavie, Juliette / Robillard, Nicolas / Puech, Julien / Lameiras, Sonia / Lucas, Marie-Laure / Nicolas, Alain / Badoual, Cécile / Rance, Bastien / Bélec, Laurent / Weiss, Laurence / Wack, Maxime / Veyer, David

Scientific reports

2021 Volume 11, Issue 1, Page(s) 4633

Abstract: Archival tissue samples collected longitudinally from a patient who died from HPV16-induced high-grade anal intraepithelial squamous cell carcinoma with vertebral HPV16-positive metastasis were retrospectively analyzed by the Capture-HPV method (Capt-HPV) ...

Abstract	Archival tissue samples collected longitudinally from a patient who died from HPV16-induced high-grade anal intraepithelial squamous cell carcinoma with vertebral HPV16-positive metastasis were retrospectively analyzed by the Capture-HPV method (Capt-HPV) followed by Next-Generation Sequencing (NGS). Full length nucleotide sequences of the same HPV16 were identified from the initial and second anal biopsy samples, from plasma sample and from vertebral metastasis biopsy. Remarkably, HPV was episomal in each sample. The HPV genome sequence was closest to the HPV16 Qv18158E variant subtype (A1 lineage) exhibiting base substitutions and deletions in 7 and 2 HPV loci, respectively. In conclusion, the powerful Capt-HPV followed by NGS allows evidencing the detailed cartography of tumoral and circulating HPV DNA, giving rise to a unique and unexpected episomal virus molecular status in a context of aggressive carcinoma, underlying the importance of HPV status and its association with clinical features for further prospective studies.
MeSH term(s)	Anus Neoplasms/blood ; Anus Neoplasms/complications ; Anus Neoplasms/pathology ; Anus Neoplasms/virology ; Carcinoma, Squamous Cell/blood ; Carcinoma, Squamous Cell/complications ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/virology ; Human papillomavirus 16/isolation & purification ; Humans ; Neoplasm Metastasis ; Papillomavirus Infections/complications ; Retrospective Studies
Language	English
Publishing date	2021-02-25
Publishing country	England
Document type	Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
ZDB-ID	2615211-3
ISSN	2045-2322 ; 2045-2322
ISSN (online)	2045-2322
ISSN	2045-2322
DOI	10.1038/s41598-021-84110-2
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab.

Morel, Antoine / Imbeaud, Sandrine / Scemla, Anne / Péré, Hélène / Fourgeaud, Jacques / Amrouche, Lucile / Robillard, Nicolas / Planas, Delphine / Puech, Julien / Simon, Sylvie / Lanternier, Fanny / Bélec, Laurent / Zuber, Julien / Schwartz, Olivier / Anglicheau, Dany / Chavarot, Nathalie / Veyer, David

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

2022 Volume 22, Issue 8, Page(s) 2099–2103

Abstract: Immunocompromised patients may experience prolonged viral shedding after their initial SARS-CoV-2 infection, however, symptomatic relapses after remission currently remain rare. We herein describe a severe COVID-19 relapse case of a kidney transplant ... ...

Abstract	Immunocompromised patients may experience prolonged viral shedding after their initial SARS-CoV-2 infection, however, symptomatic relapses after remission currently remain rare. We herein describe a severe COVID-19 relapse case of a kidney transplant recipient (KTR) following rituximab therapy, 3 months after a moderate COVID-19 infection, despite viral clearance after recovery of the first episode. During the clinical relapse, the diagnosis was established on a broncho-alveolar lavage specimen (BAL) by RT-PCR. The infectivity of the BAL sample was confirmed on a cell culture assay. Whole genome sequencing confirmed the presence of an identical stain (Clade 20A). However, it had an acquired G142D mutation and a larger deletion of 3-amino-acids at position 143-145. These mutations located within the N-terminal domain are suggested to play a role in viral entry. The diagnosis of a COVID-19 relapse should be considered in the setting of unexplained persistent fever and/or respiratory symptoms in KTRs (especially for those after rituximab therapy), even in patients with previous negative naso-pharyngeal SARS-CoV-2 PCR.
MeSH term(s)	COVID-19 ; COVID-19 Testing ; Humans ; Kidney Transplantation/adverse effects ; Recurrence ; Reverse Transcriptase Polymerase Chain Reaction ; Rituximab/therapeutic use ; SARS-CoV-2/genetics
Chemical Substances	Rituximab (4F4X42SYQ6)
Language	English
Publishing date	2022-03-01
Publishing country	United States
Document type	Case Reports
ZDB-ID	2060594-8
ISSN	1600-6143 ; 1600-6135
ISSN (online)	1600-6143
ISSN	1600-6135
DOI	10.1111/ajt.17000
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5542: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito